Reprogramming an adult cell into an induced pluripotent stem cell (iPSC) takes weeks, but fewer than one percent of cells succeed. Why the process proceeds so slowly and unevenly remained unclear until recently: researchers saw only the beginning and the end, while the intermediate states slipped away.
Scientists at UCLA led by Kathrin Plath developed a way to track changes at the level of individual cells every day. They initiated reprogramming and recorded molecular and morphological features at regular intervals. The resulting "map" showed that the stages proceed in a strict sequence and are the same for different types of source cells and different protocols.
An important clarification: this path is not a simple reversal of embryonic development. Some steps do indeed unfold in reverse order, but other cells stubbornly retain their identity until late stages. It is precisely this "reluctance" to change fate that explains the low efficiency of the process.
Researchers now have a tool that allows them to isolate cells at a specific stage and study what exactly happens at each moment. Plath and her colleagues plan to use the method to isolate intermediate populations and search for molecular "brakes" that prevent most cells from completing the transformation.
The work was carried out with support from the California Institute for Regenerative Medicine and the UCLA Stem Cell Center. The data were published in the journal Cell; these are not preliminary results but a full-fledged study with detailed temporal analysis.
Understanding the sequence of reprogramming opens the way to more controlled production of iPSCs. Instead of waiting for rare cells to reach the desired state on their own, it will become possible to intervene at specific stages and increase the yield.
Ultimately, this brings closer the moment when patient-specific stem cells become a reliable source for disease modeling and, possibly, for replacement therapy.

